Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2023 2
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Identification and management of cardiopulmonary risk in patients with COPD: a multidisciplinary consensus and modified Delphi study.
Gale CP, Hurst JR, Hawkins NM, Bourbeau J, Han MK, Lam CSP, Marciniuk DD, Price D, Stolz D, Gluckman T, Zieroth S, Nadarajah R, Young RP, Singh D, Martinez FJ, Berg DD, Bhutani M; Global Working Group on Cardiopulmonary Risk. Gale CP, et al. Eur J Prev Cardiol. 2025 Mar 3:zwaf119. doi: 10.1093/eurjpc/zwaf119. Online ahead of print. Eur J Prev Cardiol. 2025. PMID: 40037333
Utility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary hospital.
Punzalan FER, Aherrera JAM, de Paz-Silava SLM, Mondragon AV, Malundo AFG, Tan JJE, Tantengco OAG, Quebral EPB, Uy MNAR, Lintao RCV, Dela Rosa JGL, Mercado MEP, Avenilla KC, Poblete JB, Albay AB Jr, David-Wang AS, Alejandria MM. Punzalan FER, et al. Among authors: albay ab jr. Front Immunol. 2023 Feb 28;14:1123497. doi: 10.3389/fimmu.2023.1123497. eCollection 2023. Front Immunol. 2023. PMID: 36926338 Free PMC article.
Intravenous Tocilizumab versus Standard of Care in the Treatment of Severe and Critical COVID-19-related Pneumonia: A Single-center, Double-blind, Placebo-controlled, Phase 3 Trial.
Amante EJB, David-Wang AS, Tee ML, Punzalan FER, Añonuevo JC, Fernandez LC, Albay AB Jr, Malabad JCM, Climacosa FMM, Pajes ANNI, Cuaño PMGM, Alejandría MM. Amante EJB, et al. Among authors: albay ab jr. Acta Med Philipp. 2024 Apr 15;58(6):7-13. doi: 10.47895/amp.vi0.6175. eCollection 2024. Acta Med Philipp. 2024. PMID: 38846161 Free PMC article.